La Merie Company Profile
La Merie Business Intelligence provides R&D information services to the biopharmaceutical industry by individual consultancy, publication of reports and industry data. For more information visit www.lamerie.com.
Growth drivers were therapeutic antibodies; single digit growth for most therapeutic proteins; novel anti-inflammatory antibodies continue strong growth; number of blockbuster biologics increased...
The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of February 2013 provides a competitor analysis in the development pipeline of...
With over US$ 5.5 bln sales in 2009, the five recombinant products of coagulation factors VIII, IX and VIIa attracted more than 41 projects in the R&D pipeline, 12 of them already in the clin...
The progress made in the field of assisted reproductive technology is illustrated by the fact that field barely existed fifty years ago before Louise Brown was born in 1978 thanks to the genius and...
Drugs and Medications
The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.
La Merie Business Intelligence provides R&D information services to the biopharmaceutical industry by individual consultancy, publication of reports and industry data. For more in...
More Information about "La Merie" on BioPortfolio
We have published hundreds of La Merie news stories on BioPortfolio along with dozens of La Merie Clinical Trials and PubMed Articles about La Merie for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of La Merie Companies in our database. You can also find out about relevant La Merie Drugs and Medications on this site too.